Removal of cannabis from Schedule I of the Controlled Substances Act

Part of a series on
Cannabis
Arts Culture 420 (chan) Books Magu (deity) Names Religion Judaism Latter-day Saints Sikhism Smoke-in Spiritual use Sports Stoner film Stoner rock Terms
Chemistry Cannabinoid receptors Cannabinoid receptor type 1 Cannabinoid receptor type 2 Cannabinoids 2-AG 2-AGE, Noladin ether AEA CBC CBL CBD CBDV CBG CBN CBV NADA THC THCV Virodhamine Synthetic cannabinoids AM-2201 CP-55940 Dimethylheptylpyran HU-210 HU-331 JWH-018 JWH-073 JWH-133 Levonantradol SR144528 WIN 55,212-2
Consumption Drinks Edibles Smoking Tea Vaping Adult lifetime cannabis use by country Annual cannabis use by country
Economics Coffeeshop Cultivation Shop Social Club Grow house Grow shop Head shop Marijuana vending machine
Effects Dependence Driving Drug testing Effects of legalized cannabis Gateway drug theory Long term effects Medicine Memory Pregnancy Psychosis Time perception
Forms Bhang Blunt Charas Flower essential oil Hash oil Hashish Hemp Hemp beer Hemp milk Hemp oil Hemp protein Hempcrete Joint Kief Roach Synthetic cannabis Thai stick Tincture
Law Cannabis rights Legality of cannabis Timeline of cannabis law Legality of cannabis in the U.S. Legal history of cannabis in the U.S. U.S. (Medical Non-medical Timeline) Cannabis Act of Canada Cannabis in Canada Cannabis laws of Canada by province or territory Legal history of cannabis in Canada Cannabis in Malta Drug policy of the Netherlands Drug policy of Portugal
Variants Autoflowering cannabis Genus Cannabis Species Cannabis sativa Cannabis indica Cannabis ruderalis Strains Acapulco Gold Blue Dream Charlotte's web Kush Malawi Gold Sour Diesel
Related Drug culture Illegal drug trade Psychedelia
Cannabis portal Medicine portal Agriculture portal
v t e

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, in 2024, the US Department of Justice announced it was initiating rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act.